Navigation Links
Tribogenics Expands X-Ray Development Team With Key Hires
Date:5/8/2013

MARINA DEL REY, Calif., May 8, 2013 /PRNewswire/ -- Tribogenics, the pioneer of innovative X-ray solutions, announced today that it has added three key members to its research and development team. The new team members expand the company's rapid prototyping and development program, and contribute their experience from premier technology groups to add to the scientific and technical capabilities of an already impressive team.

Rajat Roychoudhury , Ph.D., Director of Engineering, has over 15 years engineering and development expertise gained at a string of successful, fast-growth technology companies including KLA-Tencor, Photondynamics, Cognex and Lam Research. Dr. Roychoudhury brings his successful track record in taking products from inception to commercialization to Tribogenics and oversees the company's product development cycle.

Eric Wong , Ph.D., Senior R&D Engineer, has over 10 years professional experience in materials chemistry and integration. He has significant experience at the Jet Propulsion Laboratory and a Ph.D. in Chemistry from Harvard. Dr. Wong leads Tribogenics' material science program, which includes developing the polymer technology integrated into the company's X-Change™ cartridge, currently the world's smallest X-ray source.

Humberto Torreblanca , Ph.D., Senior R&D Engineer, comes to Tribogenics from Intel Corporation where he was a Senior Scientist and led development on their critical etch processes. His background in plasma physics and experience in parametric analysis is accelerating the company's prototyping work and helping prepare for volume production of its X-ray solutions.

With these additions, Tribogenics expands one of the strongest X-ray technology teams in the analytical instrument industry.

About Tribogenics

Tribogenics is a transformative X-ray techn
'/>"/>

SOURCE Tribogenics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Tribogenics Announces Dual-Energy X-ray Source for XRF
2. Dr. Peter Diamandis Joins Tribogenics Advisory Board
3. As Smartphone Usage Expands, Survey Says Nurses and Nursing Students Want Mobile Access to Credible Drug Data
4. BioSurplus Expands, Debuts New 8000 Square Foot Warehouse and Service Facility
5. RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
6. Clinical Interest in BioElectronics Products Expands to the Wound Care Market
7. S1 Biopharma Expands Focus to Include Male Sexual Health
8. PRA Expands Operations in Europe
9. USANA Health Sciences Expands Award-Winning Research and Development Team
10. Particle Sciences Expands its cGMP Capabilities with the Addition of Thin Films
11. Argus Expands Specialty Pharmacy with Amber Pharmacy Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... SPRINGS, Colo. , Aug. 22, 2014 /PRNewswire/ ... specializing in cannabis formulation-based drug development and related ... UFCM iCare,s third international medical cannabis conference taking ... Strasbourg, France , on October 22, ... with other stakeholders, such as researchers, health professionals, ...
(Date:8/21/2014)... GREENWICH, Conn. , Aug. 21, 2014 /PRNewswire/ ... West Lafayette, Indiana , has ... determination and characterization of small and large molecules, ... addition of the Bruker maXisPlus Q-TOF mass spectrometer. ... Jonathan Goldman , CEO, Aptuit, said, "The expanded ...
(Date:8/21/2014)... , Aug. 21, 2014  eRelevance Corporation ( ... announced today that it has completed integration with ... for Plastic Surgery and Dermatology practices. ... value to healthcare practices using Nextech," stated ... Corporation. "Using information from the EMR we are ...
Breaking Medicine Technology:Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2eRelevance Corporation Integrates with Nextech Electronic Medical Records 2
... -- Phase II,results exceed expectations - Alchemia prepares ... company Alchemia Limited will,commence discussions with the US ... of the Phase II clinical trial,of its metastatic ... from the randomized Phase II clinical trial in ...
... data on Eloxatin(R), Taxotere(R) and on three investigational,agents ... at the 43rd,annual ASCO meeting, BRIDGEWATER, N.J., May ... total of 375 abstracts,indicative of its oncology commitment ... the American Society of Clinical Oncology,(ASCO) in Chicago, ...
Cached Medicine Technology:Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal 2Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal 3Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal 4Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 2Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 3Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 4Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 5Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 6Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 7Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 8Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 9Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 10Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 11Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 12
(Date:8/23/2014)... (PRWEB) August 23, 2014 Having been in ... dental hygienist from Arlington, Texas, saw a need for an ... toothpaste. "That’s when I came up with the idea for ... provides an effective way for a user to clean the ... to carry multiple items. It also helps avoid plaque buildup ...
(Date:8/23/2014)... (PRWEB) August 23, 2014 Hundreds ... filed on behalf of individuals who were allegedly ... replacement line continue to move forward in the ... Liebhard LLP reports. According to an Order dated ... trial program that would allow the litigation’s first ...
(Date:8/23/2014)... GBI Research, the leading business intelligence ... in Major Developed Markets to 2020 - New and ... which provides in-depth analysis of the critical care market ... and Canada. The report provides an estimation of market ... It covers critical care indications that are being treated ...
(Date:8/23/2014)... Pixel Film Studios, a leader of Final Cut ... ProIntro Vol.3, a customizable title tool for FCPX ... by dragging ProIntro Vol.3 in their timeline" says Christina Austin, ... time saver and i think our users will agree" , ... titles made with Final Cut Pro X users in mind. ...
(Date:8/23/2014)... Youth substance abuse is a serious problem across ... TX. Substance abuse can happen to people of all ... dependency in higher numbers than ever before. Many ... don’t know where to find professional youth rehab. ... because most treatment options are designed for adults. The ...
Breaking Medicine News(10 mins):Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:Critical Care Therapeutics in Major Developed Markets to 2020 | Researchmoz 2Health News:Critical Care Therapeutics in Major Developed Markets to 2020 | Researchmoz 3Health News:A new plugin was announced today, ProIntro Vol.3 from Pixel Film Studios for Final Cut Pro X 2Health News:New Houston Hotline Assisting Juveniles in Locating Dependable Rehabilitation Help 2
... Dec. 4 MedClean Technologies, Inc. (OTC Bulletin Board: MCLN) today ... with Socius Capital Group, LLC, a Delaware limited liability company, ... the Purchase Agreement, MedClean will receive up to $7.5 million in ... shares of its Series C Preferred Stock, in one or more ...
... Health Reform Bills Will Increase Deficit , WASHINGTON, Dec. 4 ... really paid for because Congress never lets Medicare savings take ... that it enacted in the past two decades to take ... Center on Budget and Policy Priorities shows. , The analysis, ...
... , SEATTLE, Dec. 4 The National Cancer Institute has ... Center to become the nation,s sole operator of its Cancer Information ... at the Hutchinson Center - nearly tripling the size of its ... which is scheduled for March 15, 2010. The Seattle CIS center ...
... December 4, 2009 -- Substantial progress has been made over ... diagnose and treat epilepsy and its complications. Yet this ... 50 million people around the world, including many of the ... the disorder, According to Steven C. Schachter, M.D., president ...
... ... annual Toy Drive benefiting Providence Hospital’s “Adopt-a-Family for Christmas” program. The goal is to ... is achieved, Bobby Berk Home will match the donation. Toys will be distributed to ... ...
... benefits are not clear enough to recommend its use, ... -- Cancer patients, glaucoma patients and others can benefit ... that it can help multiple sclerosis (MS) patients find ... of the debilitating autoimmune disease. , "The therapeutic potential ...
Cached Medicine News:Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 2Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 3Health News:Congress Has Allowed Most Previous Medicare Cuts to Take Effect, New Study Shows 2Health News:Congress Has Allowed Most Previous Medicare Cuts to Take Effect, New Study Shows 3Health News:Congress Has Allowed Most Previous Medicare Cuts to Take Effect, New Study Shows 4Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 3Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 4Health News:Bobby Berk Home and Leslie Sanchez Announce 1st Annual Toy Drive for DC's Neediest Families 2Health News:Review Finds Marijuana May Help MS Patients 2Health News:Review Finds Marijuana May Help MS Patients 3
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Medicine Products: